In addition to tumor inhibition, methylation of Pcdh10 may serve as a non-invasive biomarker for CRC diagnosis as Pcdh10 methylation that is present in tissues could be detected in serum/plasma (Danese et al. 2013). The gene discussed is PCDH10; the disease is neoplasm.